دورية أكاديمية

Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study

التفاصيل البيبلوغرافية
العنوان: Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study
المؤلفون: Poon, RTP, Decaens, T, Raoul, JL, Llovet, JM
بيانات النشر: //www.jco.org/
United States
سنة النشر: 2013
المجموعة: University of Hong Kong: HKU Scholars Hub
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0732-183X
العلاقة: Journal of Clinical Oncology; Journal of Clinical Oncology, 2013, v. 31 n. 28, p. 3509-3516; 3516; 227170; WOS:000330539000009; 28; 3509; http://hdl.handle.net/10722/193243Test; 31
DOI: 10.1200/JCO.2012.47.3009
الإتاحة: https://doi.org/10.1200/JCO.2012.47.3009Test
http://hdl.handle.net/10722/193243Test
رقم الانضمام: edsbas.A4FA9381
قاعدة البيانات: BASE
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2012.47.3009